Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • yog77
    Member
    • Jun 2011
    • 18

    #1

    Bisulphite Sequencing Proof-reading or NOT proof-reading?

    I'm in the process of applying bisulphite PCR amplicon sequencing to the Illumina platform and wondered what peoples thoughts were on whether to use a proof-reading enzyme in the PCR that can read through Uracil's on a bisulphite converted template (I have only come across these two that apparently do):

    pfu TURBO Cx Hotstart (Stratagene)
    Expand High Fidelity PLUS (Roche)

    OR

    Do I continue with the standard hotstart Taq we use in the lab for most bisulphite PCR applications which we know to work very well and gives good amplification products (also I have achieved a good optimisation of all my amplicons with this standard Taq).

    Some people say that - With the read depth provided by GAII and above, the level of fidelity of standard Taq should not have a major impact on your results. While there is a tenancy to use a proof-reading enzyme in all commercial sequence capture protocols.

    Please help - any comments would be grateful
  • shawpa
    Member
    • Aug 2011
    • 73

    #2
    I recently went through this protocol and used pfu turbo polymerase. I initially tried PCRing with the taq provided in the truseq kit which I believe is phusion polymerase but I could be wrong. That didn't work and I assumed it was because of the U's. But I guess if you have gotten the normal hotstart Taq to work for previous bisulfite products then that wouldn't be an issue for you.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 10:52 AM
    0 responses
    9 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Working...